[Drug therapy in collagen diseases].
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000962:Antimalarials / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003095:Collagen Diseases / Q000188:drug therapy* / Q000276:immunology; D003348:Cortisone / Q000627:therapeutic use; D003882:Dermatomyositis / Q000188:drug therapy; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008938:Mitosis / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012595:Scleroderma, Systemic / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D000251:Adenosine Triphosphatases; D003348:Cortisone; D011241:Prednisone
Leki stosowane w kolagenozach.